Confronting a new obstacle to reproductive choice: encouraging the development of RU-486 through reform of products liability law.
D000028:Abortion, Induced; D035881:Compensation and Redress; D006233:Persons with Disabilities; D004345:Drug Industry; D004467:Economics; D035082:Federal Government; D005602:France; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D033222:Judicial Role; D007603:Jurisprudence; D007878:Legislation as Topic; D016365:Liability, Legal; D015735:Mifepristone; D005791:Patient Care; D004364:Pharmaceutical Preparations; D012306:Risk; D018570:Risk Assessment; D012922:Social Change; D012926:Social Control, Formal; D014481:United States; D014486:United States Food and Drug Administration; D014947:Wounds and Injuries; D015974:Wrongful Life
Genetics and Reproduction; Legal Approach; Roussel Uclaf